| Authors: |
Andres-Mateos E; Atsena Therapeutics, Durham, NC 27709, USA., Kozlowski C; Atsena Therapeutics, Durham, NC 27709, USA., Zhang H; Divison of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA., Fajardo D; Divison of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA., Xu E; Divison of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA., Enamorado IN; Atsena Therapeutics, Durham, NC 27709, USA., Calabro KR; Atsena Therapeutics, Durham, NC 27709, USA., Rayaprolu S; Atsena Therapeutics, Durham, NC 27709, USA., Havlik LP; Atsena Therapeutics, Durham, NC 27709, USA., Handy TE; Atsena Therapeutics, Durham, NC 27709, USA., Plummer CE; Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA., Stevenson V; Ophthalmology Services, Charles River Laboratories, Mattawan, MI, USA., Rind H; Ophthalmology Services, Charles River Laboratories, Mattawan, MI, USA., Leahy M; Ophthalmology Services, Charles River Laboratories, Mattawan, MI, USA., Boyd RF; Ophthalmology Services, Charles River Laboratories, Mattawan, MI, USA., Coleman KE; Powell Gene Therapy Center, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA., Boye SL; Powell Gene Therapy Center, Department of Pediatrics, University of Florida, Gainesville, FL 32610, USA., Boye SE; Atsena Therapeutics, Durham, NC 27709, USA. Electronic address: shannon.boye@atsenatx.com. |
